biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a0yg-01a-21d-a10g-09
biospecimen_aliquot__bcr_aliquot_uuid	bf82035c-9cd1-4355-acdd-8a007708e976
biospecimen_aliquot__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099016242
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2010-11-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a10g
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	2.05
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a0yg-01a-21d
biospecimen_analyte__bcr_analyte_uuid	e532ff25-a7f5-4076-9ac7-2d608ffa960f
biospecimen_analyte__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a0yg
biospecimen_diagnostic_slides__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	89a39319-f880-47de-b311-da1f6a64b6f3
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a0yg
biospecimen_normal_control__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_normal_control__ncedna_dna_conc	0.163
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	122.7
biospecimen_portion__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_portion__bcr_portion_barcode	tcga-a2-a0yg-01a-21
biospecimen_portion__bcr_portion_uuid	775ac050-00f7-44cc-9b82-91a0a879c9b9
biospecimen_portion__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_portion__date_of_creation	2010-10-18
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a0yg-01a-21d
biospecimen_protocol__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_sample__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_sample__bcr_sample_uuid	5006c942-bc9a-41cb-8674-2341b4e66230
biospecimen_sample__days_to_collection	329
biospecimen_sample__initial_weight	1530
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a0yg.b3d6a0f7-5e3c-4921-8399-6458e5222cc5.pdf
biospecimen_sample__pathology_report_uuid	b3d6a0f7-5e3c-4921-8399-6458e5222cc5
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	fd5b5379-e9d1-4b05-ae35-29bd73f0c37f
biospecimen_shipment_portion__center_id	30
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a21v
biospecimen_shipment_portion__portion_number	41
biospecimen_shipment_portion__portion_sequence	4
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a0yg-01a-41-a21v-30
biospecimen_shipment_portion__shipment_portion_day_of_shipment	3
biospecimen_shipment_portion__shipment_portion_month_of_shipment	4
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
biospecimen_slide__bcr_sample_barcode	tcga-a2-a0yg-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a0yg-01a-02-bsb
biospecimen_slide__bcr_slide_uuid	23b5c2d3-91a2-4091-bd43-04210baa9941
biospecimen_slide__image_file_name	tcga-a2-a0yg-01a-02-bsb.23b5c2d3-91a2-4091-bd43-04210baa9941.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	1
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	1
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	25
biospecimen_slide__percent_tumor_cells	75
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a0yg
biospecimen_tumor_sample__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
clinical_drug__bcr_drug_barcode	tcga-a2-a0yg-d5639
clinical_drug__bcr_drug_uuid	a99a6cef-a2db-4dcb-aba7-24b62d65de98
clinical_drug__bcr_patient_barcode	tcga-a2-a0yg
clinical_drug__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
clinical_drug__form_completion_date	2010-12-14
clinical_drug__pharmaceutical_therapy_drug_name	herceptin
clinical_drug__pharmaceutical_therapy_type	targeted molecular therapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	152
clinical_drug__prescribed_dose	255-509
clinical_drug__regimen_number	6
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-a2-a0yg-f16753
clinical_follow_up__bcr_followup_uuid	ae70b861-9d94-44e5-8818-90aa283fd9c6
clinical_follow_up__bcr_patient_barcode	tcga-a2-a0yg
clinical_follow_up__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-9-16
clinical_follow_up__last_contact_days_to	666
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	63
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n3a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiic
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-a2-a0yg
clinical_patient__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
clinical_patient__birth_days_to	-23058
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-1-3
clinical_patient__gender	female
clinical_patient__her2_ihc_score	3+
clinical_patient__her2_status_by_ihc	positive
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	404
clinical_patient__lymph_nodes_examined_count	18
clinical_patient__lymph_nodes_examined_he_count	14
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0yg
clinical_patient__pr_positivity_ihc_intensity_score	2+
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a2-a0yg
clinical_radiation__bcr_patient_uuid	c0892598-1f7b-4f23-9cd8-731f797753d5
clinical_radiation__bcr_radiation_barcode	tcga-a2-a0yg-r5625
clinical_radiation__bcr_radiation_uuid	f5aff914-e9ce-4684-9fca-5e1ed11aa6c0
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-12-2
clinical_radiation__radiation_adjuvant_fractions_total	25
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	303
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	257
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	5940
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YG-01A-21D-A10G-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YG-01A-21D-A10G-09.bed.meta
manually_curated__id	tcga-a2-a0yg-01a-21d-a10g-09
manually_curated__md5sum	4463a0072368f0f03770a2283dc16c90
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	bf82035c-9cd1-4355-acdd-8a007708e976
manually_curated__tumor_tag	brca
